Aspirin's secret power: new study aims to predict preeclampsia risk

NCT ID NCT06249178

First seen Jan 05, 2026 · Last updated May 14, 2026 · Updated 23 times

Summary

This study looks at pregnant people who are at risk for preeclampsia and are taking aspirin as part of their care. Researchers will collect blood samples up to four times during pregnancy to study tiny particles from the placenta. The goal is to find a set of proteins that can show how well the placenta is working and how it responds to aspirin, which may help predict and manage preeclampsia better.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine

    RECRUITING

    Columbus, Ohio, 43210, United States

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.